Prevalence of human immunodeficiency virus/hepatitis C virus co-infection in Brazil and associated factors: A review

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages 455-463

  Kuehlkamp, Valdete Meurer ^a   Schuelter Trevisol, Fabiana ^a,b  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

Author keywords

Brazil; Co infection; Hepatitis C; HIV

Indexed keywords

BLOOD TRANSFUSION; BODY PIERCING; BRAZIL; DATA EXTRACTION; DISEASE ASSOCIATION; DRUG USE; HEPATITIS C; HIGH RISK BEHAVIOR; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INJECTION DRUG USE; INTRAVENOUS DRUG ABUSE; MIXED INFECTION; PREGNANT WOMAN; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEXUAL TRANSMISSION; SHORT SURVEY; TATTOOING;

BRAZIL; CO-INFECTION; HEPATITIS C; HIV;

ADULT; BRAZIL; COINFECTION; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; RISK FACTORS;

EID: 84880951739     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.10.023     Document Type: Short Survey

References (58)

1. Miranda A.E., Mercon-de-Vargas P.R., Viana M.C. Sexual and reproductive health of female inmates in Brazil. Rev Saude Publica 2004, 38:255-260.
2. Soriano V., Garcia-Samaniego J., Rodriguez-Rosado R., Gonzalez J., Pedreira J. Hepatitis C and HIV infection: biological, clinical, and therapeutic implications. J Hepatol 1999, 31(Suppl. 1):119-123.
3. Yen T., Keeffe E.B., Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003, 36:47-53.
4. Ragni M.V., Belle S.H. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 2001, 183:1112-1115.
5. Benhamou Y., Bochet M., Di Martino V., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999, 30:1054-1058.
6. Macias J., Berenguer J., Japon M.A., et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology 2009, 50:1056-1063.
7. Rockstroh J.K., Mocroft A., Soriano V., et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005, 192:992-1002.
8. Brasil Boletim Epidemiológico Hepatites Virais 2011, Ministério da Saúde, Brasília.
9. Carvalho F.H., Coelho M.R., Vilella Tde A., Silva J.L., Melo H.R. HIV/HCV coinfection at an university hospital in Recife. Brazil Rev Saude Publica 2009, 43:133-139.
10. Hadlich E., Alvares-Da-Silva M.R., Dal Molin R.K., Zenker R., Goldani L.Z. Hepatitis C virus (HCV) viremia in HIV-infected patients without HCV antibodies detectable by third-generation enzyme immunoassay. J Gastroenterol Hepatol 2007, 22:1506-1509.
11. Santos E.O., Coelho M.R.C.D., Vilella T.A.S., Silva J.L.A., Neto E.P.A.L. Ocorrência e fatores de risco para co-infecção pelo vírus da hepatite C (HCV) em pacientes com o vírus da imunodeficiência humana (HIV) em Maceió. Brasil Rev Para Med 2008, 22:21-27.
12. Mendes-Correa M.C., Barone A.A., Guastini C. Hepatitis C virus seroprevalence and risk factors among patients with HIV infection. Rev Inst Med Trop Sao Paulo 2001, 43:15-19.
13. Oliveira M.L., Yoshida C.F., Telles P.R., et al. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Epidemiol Infect 2009, 137:970-979.
14. Segurado A.C., Braga P., Etzel A., Cardoso M.R. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDS 2004, 18:135-143.
15. Tovo C.V., Dos Santos D.E., de Mattos A.Z., de Almeida P.R., de Mattos A.A., Santos B.R. Ambulatorial prevalence of hepatitis B and C markers in patients with human immunodeficiency virus infection in a general hospital. Arq Gastroenterol 2006, 43:73-76.
16. Victoria M.B., Victoria Fda S., Torres K.L., Kashima S., Covas D.T., Malheiro A. Epidemiology of HIV/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas. Braz J Infect Dis 2010, 14:135-140.
17. Pavan M.H., Aoki F.H., Monteiro D.T., Goncales N.S., Escanhoela C.A., Goncales Junior F.L. Viral hepatitis in patients infected with human immunodeficiency virus. Braz J Infect Dis 2003, 7:253-261.
18. Zocratto K.B., Caiaffa W.T., Proietti F.A., Carneiro-Proietti A.B., Mingoti S.A., Ribeiro G.J. HCV and HIV infection and co-infection: injecting drug use and sexual behavior, AjUDE-Brasil I Project. Cad Saude Publica 2006, 22:839-848.
19. Bonamigo R.R., Borges K., Rietjens J., Arenzon S., Blanco L.F., Loureiro R. Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients. Int J Dermatol 2004, 43:568-570.
20. Carmo R.A., Guimaraes M.D., Moura A.S., et al. The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients. Braz J Infect Dis 2008, 12:173-179.
21. Sampaio A.S., Alencar L.C.A., Moura P.M.M.F., Correia J.B., Barreto S.B., Castelo A. Prevalencia de la co-infección con hepatitis B y C en pacientes HIV positivios y fatores de riesgo asociados. Actualizaciones em SIDA 2009, 17:12-17.
22. Reis N.R., Lopes C.L., Teles S.A., et al. Hepatitis C virus infection in patients with tuberculosis in Central Brazil. Int J Tuberc Lung Dis 2011, 15:1397-1402.
23. Mussi A.D., Pereira R.A., Correa e Silva Vde A., Martins R.M., Souto F.J. Epidemiological aspects of hepatitis C virus infection among HIV-infected individuals in Mato Grosso State, Central Brazil. Acta Trop 2007, 104:116-121.
24. Pompilio M.A., Pontes E.R.J.C., Castro A.R.C.M., et al. Prevalence and epidemiology of chronic hepatitis C among prisoners of Mato Grosso do Sul State, Brazil. J Venom Anim Toxina Incl Trop Dis 2011, 17:216-222.
25. Monteiro M.R., do Nascimento M.M., Passos A.D., Figueiredo J.F. Hepatitis C: prevalence and risk factors among patients with HIV/AIDS in Belem Para, in Brazilian Amazon. Rev Soc Bras Med Trop 2004, 37(Suppl. 2):40-46.
26. Morimoto H.K., Caterino-De-Araujo A., Morimoto A.A., et al. Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Parana, Brazil. AIDS Res Hum Retroviruses 2005, 21:256-262.
27. Braga E.L., Lyra A.C., Ney-Oliveira F., et al. Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV. Braz J Infect Dis 2006, 10:17-21.
28. Catalan-Soares B.C., Almeida R.T., Carneiro-Proietti A.B. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop 2000, 33:27-30.
29. Marchesini A.M., Pra-Baldi Z.P., Mesquita F., Bueno R., Buchalla C.M. Hepatitis B and C among injecting drug users living with HIV in Sao Paulo, Brazil. Ver Saude Publica 2007, 41(Suppl. 2):57-63.
30. Brito V.O., Parra D., Facchini R., Buchalla C.M. HIV infection, hepatitis B and C and syphilis in homeless people, in the city of Sao Paulo, Brazil. Rev Saude Publica 2007, 41(Suppl. 2):47-56.
31. Rozman M.A., Alves I.S., Porto M.A., et al. HIV infection and related risk behaviors in a community of recyclable waste collectors of Santos, Brazil. Rev Saude Publica 2008, 42:838-843.
32. Guimaraes T., Granato C.F., Varella D., Ferraz M.L., Castelo A., Kallas E.G. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection. Braz J Infect Dis 2001, 5:111-118.
33. Zanetta D.M., Strazza L., Azevedo R.S., et al. HIV infection and related risk behaviours in a disadvantaged youth institution of Sao Paulo, Brazil. Int J STD AIDS 1999, 10:98-104.
34. Santos K.F., Vieira T.B., Beck S.T.B., Leal D.B.R. Alterações laboratoriais encontradas em indivíduos co-infectados pelo vírus da imunodeficiência humana (HIV) e pelo vírus da hepatite C (HCV). RBAC 2010, 42:21-24.
35. von Diemen L., De Boni R., Kessler F., Benzano D., Pechansky F. Risk behaviors for HCV- and HIV-seroprevalence among female crack users in Porto Alegre. Brazil Arch Womens Ment Health 2010, 13:185-191.
36. Tornatore M., Goncalves C.V., Bianchi M.S., et al. Co-infections associated with human immunodeficiency virus type 1 in pregnant women from southern Brazil: high rate of intraepithelial cervical lesions. Mem Inst Oswaldo Cruz 2012, 107:205-210.
37. Costa Z.B., Machado G.C., Avelino M.M., et al. Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect Dis 2009, 9:116.
38. Gardenal R.V., Figueiro-Filho E.A., Luft J.L., et al. Hepatitis C and pregnancy: an analysis of factors associated with vertical transmission. Rev Soc Bras Med Trop 2011, 44:43-47.
39. Peixoto M.F., Mattos A.A., Remiao J.O., Alexandre C.O., Lemos S.K., Azevedo A.M. Vertical transmission of hepatitis C virus in a hospital in southern Brazil. Arq Gastroenterol 2004, 41:84-87.
40. Dal Fabbro M.M., Cunha R.V., Paniago A.M., Lindenberg Ade S., Freitas G.M., Nogueira S.A. Prospective study on the prevention of vertical transmission of HIV in Campo Grande, Mato Grosso do Sul, Brazil, from 1996 to 2001. Braz J Infect Dis 2005, 9:20-27.
41. Berra J.A.P., Bacetti L.B., Buzo A.A. Soroprevalêncai de HIV, sífilis, hepatite B e C em mulheres do Centro de Ressocialização Feminino, Rio Claro, São Paulo. Rev Inst Adolfo Lutz 2006, 65:133-136.
42. Pereira G.A., Stefani M.M., Martelli C.M., et al. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil. J Med Virol 2006, 78:719-723.
43. Braga W.S., da Costa Castilho M., dos Santos I.C., Moura M.A., Segurado A.C. Low prevalence of hepatitis B virus, hepatitis D virus and hepatitis C virus among patients with human immunodeficiency virus or acquired immunodeficiency syndrome in the Brazilian Amazon basin. Rev Soc Bras Med Trop 2006, 39:519-522.
44. Corvino S.M., Henriques R.M.S., Grotto R.M.T., Pardini M.I.M.C. Co-infecção HIV/HCV em pacientes de Botucatu e região. Rev Bras Epidemiol 2007, 10:537-543.
45. Wolff F.H., Fuchs S.C., Barcellos N.N., et al. Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates. PLoS ONE 2010, 5:e10494.
46. Marins J.R., Barros M.B., Machado H., Chen S., Jamal L.F., Hearst N. Characteristics and survival of AIDS patients with hepatitis C: the Brazilian National Cohort of 1995-1996. AIDS 2005, 19(Suppl. 4):S27-S30.
47. Treitinger A., Spada C., Silva E.L., et al. Prevalence of serologic markers of HBV and HCV infection in HIV-1 seropositive patients in Florianopolis, Brazil. Braz J Infect Dis 1999, 3:1-5.
48. Gabe C., Lara G.M. Prevalência de anti-HCV, anti-HIV e co-infecção HCV/HIV em um presídio feminino do Estado do Rio Grande do Sul. RBAC 2008, 40:87-89.
49. Portelinha Filho A.M., Nascimento C.U., Tannouri T.N., et al. Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of Sao Paulo, Brazil. Mem Inst Oswaldo Cruz 2009, 104:960-963.
50. Gois S.M., Santos Junior H.P., Silveira Mde F., Gaudencio M.M. Beyond bars and punishments: a systematic review of prison health. Cien Saude Colet 2012, 17:1235-1246.
51. Loko M.A., Salmon D., Carrieri P., et al. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis 2010, 10:303.
52. Mboto C.I., Fielder M., Davies-Russell A., Jewell A.P. Prevalence of HIV-1, HIV-2, hepatitis C and co-infection in The Gambia. West Afr J Med 2009, 28:16-19.
53. Brasil Boletim Epidemiológico Aids e DST 2010, Ministério da Saúde, Brasília.
54. Napoli C., Tafuri S., Pignataro N., Tedesco G., Maria A.S., Quarto M. Risk factors for HBV/HIV/HCV in drug addicts: a survey of attendees of a department of pathological dependence. J Prev Med Hyg 2010, 51:101-104.
55. Yan Y.X., Gao Y.Q., Sun X., et al. Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect 2011, 139:354-360.
56. Tedder R.S., Gilson R.J., Briggs M., et al. Hepatitis C virus: evidence for sexual transmission. BMJ 1991, 302:1299-1302.
57. Vogler I.H., Nishiya A., Morimoto H.K., et al. Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002. Rev Inst Med Trop Sao Paulo 2004, 46:303-308.
58. Zhang Y., Chen P., Lu R., et al. Prevalence of HIV among men who have sex with men in Chongqing, China, 2006-2009: cross-sectional biological and behavioural surveys. Sex Transm Infect 2012, 88:444-450.